These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antibiotic use in neonatal sepsis. Yurdakök M Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468 [TBL] [Abstract][Full Text] [Related]
7. Trends in antimicrobial resistance among today's bacterial pathogens. Thornsberry C Pharmacotherapy; 1995; 15(1 Pt 2):3S-8S. PubMed ID: 7753690 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [TBL] [Abstract][Full Text] [Related]
9. Problems and mechanisms of antimicrobial resistance. Murray BE Infect Dis Clin North Am; 1989 Sep; 3(3):423-39. PubMed ID: 2671132 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus. Cunha BA Med Clin North Am; 2006 Nov; 90(6):1165-82. PubMed ID: 17116442 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of antimicrobial resistance in bacteria. Tenover FC Am J Med; 2006 Jun; 119(6 Suppl 1):S3-10; discussion S62-70. PubMed ID: 16735149 [TBL] [Abstract][Full Text] [Related]
13. Emerging antibiotic-resistant bacteria. Their treatment in total joint arthroplasty. Garvin KL; Hinrichs SH; Urban JA Clin Orthop Relat Res; 1999 Dec; (369):110-23. PubMed ID: 10611866 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004). Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511 [TBL] [Abstract][Full Text] [Related]
18. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911 [TBL] [Abstract][Full Text] [Related]
19. Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. Bonomo RA Clin Infect Dis; 2000 Dec; 31(6):1414-22. PubMed ID: 11096012 [TBL] [Abstract][Full Text] [Related]
20. [Mechanisms behind the development of antibiotic resistant bacteria]. Gaustad P Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3090-4. PubMed ID: 11757446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]